{
    "2020-02-07": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Lilly to Participate in Guggenheim Healthcare Talks Idea Forum",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Guggenheim",
                        "Healthcare",
                        "Talks"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-27",
                "original_text": "Teva (TEVA) to Report Q4 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Teva",
                        "Q4",
                        "Earnings"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Assertio",
                        "Opioid",
                        "Milestone",
                        "Aduro",
                        "Myriad",
                        "CEO",
                        "Resigns"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}